Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ)
- 浏览2
Supportive care in cancer
4365-4375页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



